Who owns HIMS?

Who Owns HIMS?

HIMS & Hers is a telehealth company that offers a range of healthcare services, including treatments for erectile dysfunction, hair loss, and skin conditions. The company was founded in 2017 by Andrew Dudum (CEO), Hilary Coles, Jack Abraham, and Joe Spector of venture studio Atomic.

HIMS & Hers is headquartered in San Francisco, California, and has raised over $100 million in funding from investors such as Andreessen Horowitz, GGV Capital, and Redpoint Ventures. The company has been praised for its innovative approach to healthcare and its focus on providing affordable and accessible care to patients.

In 2021, HIMS & Hers went public on the New York Stock Exchange (NYSE). The company’s shares are currently trading at around $15 per share, giving the company a market capitalization of approximately $1.5 billion.

The company’s largest shareholder is Atomic, which owns approximately 20% of the company’s shares. Other major shareholders include Andreessen Horowitz (15%), GGV Capital (10%), and Redpoint Ventures (5%).

HIMS & Hers has been growing rapidly in recent years, and the company is expected to continue to grow in the future. The company’s focus on providing affordable and accessible healthcare is likely to continue to attract customers, and the company’s strong financial position will allow it to continue to invest in new products and services.